Clinical Trials Browser

Phase 2 × Thymoma × amrubicin × Clear all

NCT01364727 2019-04-16

A Phase 2 Study of Amrubicin in Relapsed or Refractory Thymic Malignancies

Phase 2 Completed

33 enrolled 11 charts

Thymoma, Thymus Neoplasms